Mary Kay Adds Clinical Solutions Dynamic Wrinkle Limiter to Dermocosmetic Skincare Line

Mary Kay has added the Clinical Solutions Dynamic Wrinkle Limiter to its line of dermocosmetic skincare line.

The “no-needle” alternative to professional injectables is a non-invasive at-home targeted cream that is clinically shown to be 76% as effective as a widely used wrinkle-relaxing injection treatment, based on an independent clinical bioinstrumentation study of 10 women who received a by-appointment wrinkle limiting treatment. Formulated with Mary Kay’s patent-pending Botanical Wrinkle Limiting Technology, this topical cream helps minimize the impact of facial expressions that cause the appearance of dynamic wrinkles for real results with no frozen face effect.

Clinical Solutions Dynamic Wrinkle Limiter is clinically shown to visibly reduce lines in the forehead, crow’s feet and between brows (“11” lines) in four weeks. With continued use, wrinkles appear 36% smoother in the forehead and crow’s feet (areas and 30% smoother between brows after eight weeks.

Its patent-pending Botanical Wrinkle-Limiting Technology key actives include French lavender extract to help minimize the impact of facial expressions, which cause dynamic wrinkles; electric daisy extract (Acmella oleracea)—a known wrinkle relaxant; rosemary extract (Rosmarinus officinalis), which helps minimize the impact of facial expressions which cause dynamic wrinkles.

Clinical Solutions Dynamic Wrinkle Limiter retails for $58 on marykay.com.